Seres Therapeutics Inc (MCRB) EPS is poised to hit -0.20 next quarter: How Investors Can Make It Count the Most?
As on Wednesday, Seres Therapeutics Inc (NASDAQ: MCRB) got off with the flyer as it spiked 4.33% to $0.92, before settling in for the price